Fiduciary Trust CO Dexcom Inc Transaction History

Fiduciary Trust CO

$6.5 Billion
Q2 2024

A detailed history of Fiduciary Trust CO transactions in Dexcom Inc stock. As of the latest transaction made, Fiduciary Trust CO holds 6,592 shares of DXCM stock, worth $441,795. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,592

Previous 6,592 -0.0%

Holding current value

$441,795

Previous $914,000 18.27%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $342 - $420	-3 Reduced 0.05%	6,592 $914,000
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $27,553 - $45,318	-365 Reduced 5.24%	6,595 $818,000
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $172 - $275	-2 Reduced 0.03%	6,960 $649,000
Q2 2023 Aug 01, 2023	SELL	$112.47 - $130.98 $15,408 - $17,944	-137 Reduced 1.93%	6,962 $894,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $4,576 - $5,408	-44 Reduced 0.62%	7,099 $824,000
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $9,432 - $13,616	-111 Reduced 1.53%	7,143 $808,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $369,049 - $721,326	5,428 Added 297.26%	7,254 $541,000
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $26,812 - $37,107	285 Added 18.49%	1,826 $934,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $18,701 - $23,446	-144 Reduced 8.55%	1,541 $827,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $10,671 - $14,318	100 Added 6.31%	1,685 $921,000
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $4,049 - $5,396	50 Added 3.26%	1,585 $677,000
Q1 2021 May 19, 2021	BUY	$84.79 - $104.74 $6,274 - $7,750	74 Added 5.07%	1,535 $552,000
Q4 2020 Jan 26, 2021	BUY	$78.0 - $104.5 $14,274 - $19,123	183 Added 14.32%	1,461 $540,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $3,056 - $3,614	-32 Reduced 2.44%	1,278 $527,000
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $1,567 - $2,633	25 Added 1.95%	1,310 $531,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $2,580 - $4,084	54 Added 4.39%	1,285 $346,000
Q4 2019 Feb 04, 2020	SELL	$36.62 - $57.29 $73,862 - $115,553	-2,017 Reduced 62.1%	1,231 $269,000
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $6,857 - $8,453	-193 Reduced 5.61%	3,248 $485,000
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $6,264 - $8,757	-225 Reduced 6.14%	3,441 $516,000
Q1 2019 May 07, 2019	SELL	$28.07 - $38.18 $2,807 - $3,818	-100 Reduced 2.66%	3,666 $437,000
Q4 2018 Jan 29, 2019	SELL	$26.99 - $37.37 $4,291 - $5,941	-159 Reduced 4.05%	3,766 $451,000
Q2 2018 Aug 03, 2018	SELL	$17.54 - $25.22 $2,104 - $3,026	-120 Reduced 2.97%	3,925 $373,000
Q1 2018 May 08, 2018	SELL	$13.06 - $18.54 $9,142 - $12,978	-700 Reduced 14.75%	4,045 $300,000
Q4 2017 Jan 29, 2018	SELL	$11.12 - $15.38 $25,298 - $34,989	-2,275 Reduced 32.41%	4,745 $272,000
Q3 2017 Nov 02, 2017	BUY	$11.36 - $18.98 $79,747 - $133,239	7,020	7,020 $343,000

Others Institutions Holding DXCM

# of Institutions

1,113

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Account

Fiduciary Trust CO Dexcom Inc Transaction History